Join to view full profile
Winship Cancer Institute at Emory Johns Creek Hospital6335 Hospital PkwyJohns Creek, GA 30097
Dr. Inal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Cengiz Inal, MD, is a specialist in Oncology currently working at Emory Johns Creek Hospital in Johns Creek, GA. His educational journey comprises completion of a Fellowship in Hematology and Medical Oncology, a Residency in Internal Medicine at the Montefiore Medical Center/Albert Einstein College of Medicine, an Internship in Internal Medicine at Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical Center, and his graduation from Hacettepe University FOM. Previously, Dr. Inal has been employed at Riverside Regional Medical Center and Salem Veterans Affairs Medical Center. He has contributed to the field with two recognized publications.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2012 - 2015- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2010 - 2012
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterInternship, Internal Medicine, 2009 - 2010
Hacettepe University FOMClass of 2007
Certifications & Licensure
GA State Medical License 2023 - 2028
VA State Medical License 2015 - 2024
MD State Medical License 2015 - 2016
WV State Medical License 2015 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 249 citationsDisialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.Bassel Nazha, Cengiz Inal, Taofeek K. Owonikoko
Frontiers in Oncology. 2020-07-07 - 21 citationsEmerging treatment for advanced lung cancer with EGFR mutationCengiz Inal, Emrullah Yilmaz, Bilal Piperdi, Roman Perez-Soler, Haiying Cheng
Expert Opinion on Emerging Drugs. 2015-07-08
Professional Memberships
- Associate
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: